Identification ofBRAFKinase Domain Duplications Across Multiple Tumor Types and Response to RAF Inhibitor Therapy

JAMA Oncology - United States
doi 10.1001/jamaoncol.2015.4437
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Medical Association (AMA)

Related search

Response of Single Leukemic Cells to Peptidase Inhibitor Therapy Across Time and Dose Using a Microfluidic Device

Integrative Biology (United Kingdom)
BiochemistryBiophysics
2014English

Serum Interleukin-8 Reflects Tumor Burden and Treatment Response Across Malignancies of Multiple Tissue Origins

Clinical Cancer Research
Cancer ResearchOncology
2014English

Energy Status Parameters, Hypoxia Fraction and Radiocurability Across Tumor Types

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
1995English

EGFR Activation Constitutes an Adaptive Response to BRAF Inhibitor Therapy

Cancer Discovery
Oncology
2014English

Combinatorial Therapies to Overcome B-Raf Inhibitor Resistance in Melanomas

Pharmacogenomics
Molecular MedicineGeneticsPharmacology
2012English

Which Clicks Lead to Conversions? - Modeling User-Journeys Across Multiple Types of Online Advertising

2013English

Identification of Human Haploinsufficient Genes and Their Genomic Proximity to Segmental Duplications

European Journal of Human Genetics
Genetics
2008English

Tumor Cell Response to Bevacizumab Single Agent Therapy in Vitro

Cancer Cell International
Cancer ResearchOncologyGenetics
2013English

Immune Cell Types and Secreted Factors Contributing to Inflammation-To-Cancer Transition and Immune Therapy Response

Cell Reports
BiochemistryGeneticsMolecular Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy